Astrazencea Pharma India has surged 9% to Rs 813 after the company said its net losses almost halved to Rs 18.58 crore for the quarter ended March 2013 due to lower staff cost. The pharmaceutical company had loss of Rs 33.01 crore in a year ago quarter.
“Net sales rose 3.45% to Rs 94.85 crore in the quarter ended March 2013 as against Rs 91.69 crore during the previous quarter ended March 2012,” Astrazencea Pharma India said in statement.
During the quarter under review, staff cost has declined by 36% to Rs 36.82 crore from Rs 57.91 crore in the corresponding quarter of previous year.
The stock opened at Rs 768 and hit a high of Rs 867 on NSE. The counter have seen huge trading activity with a combined 576,470 shares changing hands till 1158 hours compare to an average sub 65,000 shares that were traded daily in past two weeks on NSE and BSE.
“Net sales rose 3.45% to Rs 94.85 crore in the quarter ended March 2013 as against Rs 91.69 crore during the previous quarter ended March 2012,” Astrazencea Pharma India said in statement.
During the quarter under review, staff cost has declined by 36% to Rs 36.82 crore from Rs 57.91 crore in the corresponding quarter of previous year.
The stock opened at Rs 768 and hit a high of Rs 867 on NSE. The counter have seen huge trading activity with a combined 576,470 shares changing hands till 1158 hours compare to an average sub 65,000 shares that were traded daily in past two weeks on NSE and BSE.
